J.W. Petitpas - Concepedia

Author

J.W. Petitpas

Pfizer (United States)

Also Known As

J Petitpas, J W Petitpas, J. Petitpas, J. W. PETITPAS, J.W. Petitpas, JOAN W. PETITPAS, Joan Petitpas, Joan W. Petitpas

Publications

846

Citations

H-Index

Concepts

All Affiliations

Pfizer (United States)

About

J.W. Petitpas is an author at Pfizer (United States) specializing in medicine, drug resistance, and microbiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	537
2	Health Sciences	2	2	109
3	Natural Sciences	1	1	12
4	Biochemistry	1	1	52
5	Metabolism	1	1	52

J.W. Petitpas

Publications

839

Citations

H-Index

Page 1

	Year	Citations
<b>Molecular cloning and functional analysis of a novel macrolide‐resistance determinant, <i>mefA</i>, from <i>Streptococcus pyogenes</i></b> Joanna Clancy, J.W. Petitpas, Fadia B. Dib-Hajj, Molecular Microbiology Novel Macrolide‐resistance DeterminantBacteriologyMolecular BiologyFunctional AnalysisAntibiotic Resistance	1996	360
Two New Mechanisms of Macrolide Resistance in Clinical Strains of <i>Streptococcus pneumoniae</i> from Eastern Europe and North America Amelia Tait‐Kamradt, Todd A. Davies, Peter C. Appelbaum, Antimicrobial Agents and Chemotherapy	2000	255
Cloning and characterization of a novel macrolide efflux gene, mreA, from Streptococcus agalactiae J. P. Clancy, Fadia B. Dib-Hajj, J.W. Petitpas, Antimicrobial Agents and Chemotherapy BacteriologyStaphylococcus AureusMolecular BiologyEscherichia ColiAntibiotic Resistance	1997	87
The metabolism of glyceride glycolipids. II. Biosynthesis of monogalactosyl diglyceride from uridine diphosphate galactose and diglyceride in brain David A. Wenger, J.W. Petitpas, Ronald A. Pieringer Biochemistry BiosynthesisMonogalactosyl DiglycerideUridine Diphosphate GalactoseBiochemistryLipid Metabolism	1968	52
Assays to Detect and Characterize Synthetic Agents that Inhibit the ErmC Methyltransferase. Joanna Clancy, Brenda J. Schmieder, J.W. Petitpas, The Journal of Antibiotics	1995	35
Cyclic homopentapeptides 1. Analogs of tuberactinomycins and capreomycin with activity against vancomycin-resistant enterococci and Pasteurella John P. Dirlam, ANNETTE M. BELTON, N. C. BIRSNER, Bioorganic & Medicinal Chemistry Letters Antimicrobial SusceptibilityHealth SciencesAntibioticsMedicineVancomycin-resistant Enterococci	1997	22
Cyclic homopentapeptides 3. Synthetic modifications to the capreomycins and tuberactinomycins: Compounds with activity against methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci R. G. II LINDE, N. C. BIRSNER, R.Y. Chandrasekaran, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistrySynthetic ModificationsMethicillin-resistant Staphylococcus AureusAntibioticsMedicine	1997	16
Cyclic homopentapeptides 2. Synthetic modifications of viomycin Joe Lyssikatos, Shang-Poa Chang, J. P. Clancy, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistrySynthetic ModificationsBioorganic ChemistryHeterocyclicNatural Sciences	1997	12

Page 1